Ginkgo Bioworks Holdings, Inc. Balance Sheet
DNA / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Ginkgo Bioworks Holdings, Inc. had $1.1B in total assets and $509M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167.2M | $561.6M | $944.1M | $1.3B | $1.6B | $380.8M | $495.3M |
| Accounts Receivable | $24.0M | $21.9M | $17.2M | $80.9M | $131.5M | $16.7M | - |
| Inventory | - | - | $46.0K | $4.4M | $3.4M | $2.7M | - |
| Current Assets | $471.8M | $602.7M | $1.0B | $1.5B | $1.7B | $426.5M | - |
| PP&E (Net) | $167.8M | $203.7M | $188.2M | $314.8M | $145.8M | $121.4M | - |
| Goodwill | - | $0 | $49.2M | $60.2M | $21.3M | $1.9M | $1.9M |
| Total Assets | $1.1B | $1.4B | $1.7B | $2.5B | $2.1B | $675.2M | - |
| Current Liabilities | $96.0M | $107.3M | $163.9M | $173.0M | $134.8M | $73.2M | - |
| Shareholders' Equity | $508.6M | $716.1M | $1.1B | $1.7B | $1.5B | $470.1M | $501.9M |